Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZYPREXA
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors
- The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery
- Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
- Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
- Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.
- Olanzapine for the Prevention of Postoperative Nausea and Vomiting
- Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
- Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
- "Extended" (Alternate Day) Antipsychotic Dosing
- Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
- Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
- Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
- Oral Olanzapine Versus Haloperidol or Diazepam
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
- Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
- Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
- Olanzapine for Nausea After Surgery
- Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
- Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
- 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
- IM Olanzapine Versus Haloperidol or Midazolam
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
- Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
- Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
- A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
- A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
- Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
- Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition
- Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study
- Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Bergen Psychosis Project 2 - The Best Intro Study
- Sustaining Remission of Psychotic Depression
- Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
- Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
- A Long-Term, Open-Label, Study on Schizophrenia
- Clozapine and Olanzapine Treatment of Aggression
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms
- Study in Adolescents With Schizophrenia or Bipolar Disorder
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
- Tardive Dyskinesia and Cognitive Function
- Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
- Metabolic Effects of Antipsychotic Substitution in Children
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Haloperidol vs Olanzapine for the Management of ICU Delirium
- D-serine Monotherapy for Schizophrenia
- Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia
- Efficacy of Lu 31-130 in Patients With Schizophrenia
- A Study in the Treatment of Acute Mania
- Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
- Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
- A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
- Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery
- Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
- Phase IIA Study in Patients With Schizophrenia
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
- Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial
- Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
- Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg
- Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
- Effects of Modafinil on Olanzapine Weight Gain
- Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Olanzapine Treatment of Patients With Bipolar I Disorder
- Olanzapine in Patients With Advanced Cancer and Weight Loss
- Zyprexa and Task Engagement in Schizophrenia
- Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
- Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
- Medication, Weight Gain and GI Hormones
- Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
- A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
- Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Ziprasidone And Olanzapine's Outcomes In Mania
- Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
- PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
- Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
- Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
- Olanzapine in the Treatment of Patients With Anorexia Nervosa
- An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)
- Metabolic Effects of Antipsychotics in Children
- A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
- Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
- Short Term Rescue Study of Olanzapine
- Long-Term Olanzapine Treatment in Children With Autism
- Cognition, Functioning and Quality of Life
- Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)
- Energy Homeostasis Under Treatment With Atypical Antipsychotics
- Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
- Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
- Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
- Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
- Study of Pharmacotherapy of Psychotic Depression
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
- Treating Drug-Resistant Childhood Schizophrenia
- Treatment and Outcome of Early Onset Bipolar Disorder
- Switching Medication to Treat Schizophrenia
- Treatment for First-Episode Schizophrenia
Clinical trials list
click for details